Company Valuation: COSMOS Pharmaceutical Corporation

Data adjusted to current consolidation scope
Fiscal Period: May 2022 2023 2024 2025 2026 2027 2028 2029
Market Cap 1 483,107 525,081 502,890 700,001 476,495 492,108 - -
Change - 8.69% -4.23% 39.2% -31.93% 3.28% - -
Enterprise Value (EV) 1 450,132 497,354 477,918 692,920 476,495 520,533 529,727 535,408
Change - 10.49% -3.91% 44.99% -31.23% 9.24% 1.77% 1.07%
P/E 20.9x 22.1x 20.6x 22.6x 14.9x 15.3x 14.4x 13.5x
PBR 2.54x 2.49x 2.17x 2.72x 1.68x 1.59x 1.46x 1.35x
PEG - 7.98x 7.61x 0.8x 4.32x 100.5x 2.3x 2.03x
Capitalization / Revenue 0.64x 0.63x 0.52x 0.69x 0.43x 0.42x 0.39x 0.36x
EV / Revenue 0.6x 0.6x 0.5x 0.69x 0.43x 0.44x 0.42x 0.39x
EV / EBITDA 10x 10.5x 9.29x 11.1x 7.12x 7.37x 7x 6.6x
EV / EBIT 15.1x 16.5x 15.2x 17.1x 11.3x 11.8x 11.2x 10.6x
EV / FCF -39.1x 93.5x -222x -807x -20.6x -65.9x -183x -845x
FCF Yield -2.56% 1.07% -0.45% -0.12% -4.85% -1.52% -0.55% -0.12%
Dividend per Share 2 40 50 60 70 82 85.3 90.01 94.2
Rate of return 0.66% 0.75% 0.95% 0.79% 1.36% 1.37% 1.45% 1.52%
EPS 2 292.4 300.5 308.6 390.9 404.3 404.9 430.3 459
Distribution rate 13.7% 16.6% 19.4% 17.9% 20.3% 21.1% 20.9% 20.5%
Net sales 1 755,414 827,697 964,989 1,011,390 1,099,583 1,182,344 1,271,788 1,369,821
EBITDA 1 44,906 47,496 51,425 62,633 66,929 70,584 75,645 81,080
EBIT 1 29,796 30,128 31,501 40,404 42,353 44,273 47,144 50,404
Net income 1 23,155 23,797 24,454 30,978 32,046 32,103 34,113 36,374
Net Debt 1 -32,975 -27,727 -24,972 -7,081 - 28,425 37,619 43,300
Reference price 2 6,100.00 6,630.00 6,345.00 8,832.00 6,012.00 6,209.00 6,209.00 6,209.00
Nbr of stocks (in thousands) 79,198 79,198 79,258 79,257 79,257 79,257 - -
Announcement Date 11/07/22 10/07/23 12/07/24 11/07/25 13/07/26 - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
20.5x0.35x5.55x2.25% 6.17B
15.33x0.44x7.37x1.37% 3.13B
14.37x0.36x5.27x1.51% 2.88B
12.77x0.42x5.3x3.8% 2.7B
19.13x0.74x10.31x1.65% 2.31B
14.67x0.45x4.28x3.81% 1.47B
Average 16.13x 0.46x 6.35x 2.4% 3.11B
Weighted average by Cap. 16.94x 0.43x 6.26x 2.26%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 3349 Stock
  4. CSMYF Stock
  5. Valuation COSMOS Pharmaceutical Corporation